CHEMED CORPORATION Proceeds and Excess Tax Benefit from Share-based Compensation
CHEMED CORPORATION (CHE) reported Proceeds and Excess Tax Benefit from Share-based Compensation of $9.90 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Compensation Related Costs
us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation · last filed 2022-02-28
- CHEMED CORPORATION proceeds and excess tax benefit from share-based compensation for the quarter ending 2021-12-31 was $4.60M, a 25.81% decline year-over-year.
- CHEMED CORPORATION proceeds and excess tax benefit from share-based compensation for the quarter ending 2021-09-30 was $1.20M, a 83.33% decline year-over-year.
- CHEMED CORPORATION proceeds and excess tax benefit from share-based compensation for the quarter ending 2021-06-30 was $868.00K, a 89.41% decline year-over-year.
- CHEMED CORPORATION proceeds and excess tax benefit from share-based compensation for the quarter ending 2021-03-31 was $3.20M, a 30.43% decline year-over-year.
- CHEMED CORPORATION proceeds and excess tax benefit from share-based compensation for fiscal 2021 was $9.90M, a 62.07% decline from fiscal 2020.
- CHEMED CORPORATION proceeds and excess tax benefit from share-based compensation for fiscal 2020 was $26.10M, a 7.85% increase from fiscal 2019.
- CHEMED CORPORATION proceeds and excess tax benefit from share-based compensation for fiscal 2019 was $24.20M, a 5.68% increase from fiscal 2018.
- CHEMED CORPORATION proceeds and excess tax benefit from share-based compensation for fiscal 2018 was $22.90M.
| Period end | Proceeds and Excess Tax Benefit from Share-based Compensation 3 month | Proceeds and Excess Tax Benefit from Share-based Compensation 6 month | Proceeds and Excess Tax Benefit from Share-based Compensation 9 month | Proceeds and Excess Tax Benefit from Share-based Compensation 12 month |
|---|---|---|---|---|
| 2021-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $5.80M derived: sum of 2 quarters · filed 2022-02-28 | $6.67M derived: sum of 3 quarters · filed 2022-02-28 | $9.90M 10-K · filed 2022-02-28 |
| 2021-09-30 | $1.20M 10-Q · filed 2021-11-01 | $2.07M derived: sum of 2 quarters · filed 2021-11-01 | $5.30M 10-Q · filed 2021-11-01 | $11.47M derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-06-30 | $868.00K 10-Q · filed 2021-07-30 | $4.10M 10-Q · filed 2021-07-30 | $10.27M derived: sum of 3 quarters · filed 2022-02-28 | $17.47M derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-03-31 | $3.20M 10-Q · filed 2021-04-30 | $9.40M derived: sum of 2 quarters · filed 2022-02-28 | $16.60M derived: sum of 3 quarters · filed 2022-02-28 | $24.80M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $13.40M derived: sum of 2 quarters · filed 2022-02-28 | $21.60M derived: sum of 3 quarters · filed 2022-02-28 | $26.10M 10-K · filed 2022-02-28 |
| 2020-09-30 | $7.20M 10-Q · filed 2021-11-01 | $15.40M derived: sum of 2 quarters · filed 2021-11-01 | $19.90M 10-Q · filed 2021-11-01 | $25.50M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $8.20M 10-Q · filed 2021-07-30 | $12.80M 10-Q · filed 2021-07-30 | $18.30M derived: sum of 3 quarters · filed 2022-02-28 | $27.10M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $4.60M 10-Q · filed 2021-04-30 | $10.10M derived: sum of 2 quarters · filed 2022-02-28 | $18.90M derived: sum of 3 quarters · filed 2022-02-28 | $22.10M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $14.30M derived: sum of 2 quarters · filed 2022-02-28 | $17.50M derived: sum of 3 quarters · filed 2022-02-28 | $24.20M 10-K · filed 2022-02-28 |
| 2019-09-30 | $8.80M 10-Q · filed 2020-11-04 | $12.00M derived: sum of 2 quarters · filed 2020-11-04 | $18.70M 10-Q · filed 2020-11-04 | $23.00M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $3.20M 10-Q · filed 2020-07-31 | $9.90M 10-Q · filed 2020-07-31 | $14.20M derived: sum of 3 quarters · filed 2021-02-26 | $17.30M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $6.70M 10-Q · filed 2020-05-01 | $11.00M derived: sum of 2 quarters · filed 2021-02-26 | $14.10M derived: sum of 3 quarters · filed 2021-02-26 | $25.80M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $7.40M derived: sum of 2 quarters · filed 2021-02-26 | $19.10M derived: sum of 3 quarters · filed 2021-02-26 | $22.90M 10-K · filed 2021-02-26 |
| 2018-09-30 | $3.10M 10-Q · filed 2019-11-04 | $14.80M derived: sum of 2 quarters · filed 2019-11-04 | $18.60M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $11.70M 10-Q · filed 2019-07-31 | $15.50M 10-Q · filed 2019-07-31 | ||
| 2018-03-31 | $3.80M 10-Q · filed 2019-05-02 | |||
| 2017-09-30 | $1.80M 10-Q · filed 2018-11-02 | $4.40M derived: sum of 2 quarters · filed 2018-11-02 | $8.10M 10-Q · filed 2018-11-02 | |
| 2017-06-30 | $2.60M 10-Q · filed 2018-07-30 | $6.30M 10-Q · filed 2018-07-30 | ||
| 2017-03-31 | $3.70M 10-Q · filed 2018-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |